Literature DB >> 16695125

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VII. CONCENTRATED HUMAN SERUM ALBUMIN.

C A Janeway1, S T Gibson, L M Woodruff, J T Heyl, O T Bailey, L R Newhouser.   

Abstract

Entities:  

Year:  1944        PMID： 16695125      PMCID： PMC435363          DOI： 10.1172/JCI101514

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  12 in total

1.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VI. THE OSMOTIC PRESSURE OF PLASMA AND OF SERUM ALBUMIN.

Authors:  G Scatchard; A C Batchelder; A Brown
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

2.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.

Authors:  E J Cohn; J L Oncley; L E Strong; W L Hughes; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

3.  CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER.

Authors:  J G Gibson; W A Evans
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

4.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. IV. A STUDY OF THE THERMAL STABILITY OF HUMAN SERUM ALBUMIN.

Authors:  G Scatchard; S T Gibson; L M Woodruff; A C Batchelder; A Brown
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

5.  CLINICAL STUDIES OF THE BLOOD VOLUME. IV. ADAPTATION OF THE METHOD TO THE PHOTOELECTRIC MICROCOLORIMETER.

Authors:  J G Gibson; K A Evelyn
Journal:  J Clin Invest       Date:  1938-03       Impact factor: 14.808

6.  THE EFFECT OF A SINGLE INJECTION OF CONCENTRATED HUMAN SERUM ALBUMIN ON CIRCULATING PROTEINS AND PROTEINURIA IN NEPHROSIS.

Authors:  J A Luetscher
Journal:  J Clin Invest       Date:  1944-05       Impact factor: 14.808

7.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. III. AMINO ACID COMPOSITION OF PLASMA PROTEINS.

Authors:  E Brand; B Kassell; L J Saidel
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

8.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VIII. CLINICAL USE OF CONCENTRATED HUMAN SERUM ALBUMIN IN SHOCK, AND COMPARISON WITH WHOLE BLOOD AND WITH RAPID SALINE INFUSION.

Authors:  A Cournand; R P Noble; E S Breed; H D Lauson; E de F Baldwin; G B Pinchot; D W Richards
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

9.  CIRCULATORY FAILURE IN ACUTE INFECTIONS.

Authors:  R V Ebert; E A Stead
Journal:  J Clin Invest       Date:  1941-11       Impact factor: 14.808

10.  STUDIES ON THE PLASMA PROTEINS. V. THE EFFECT OF CONCENTRATED SOLUTIONS OF HUMAN AND BOVINE SERUM ALBUMIN ON BLOOD VOLUME AFTER ACUTE BLOOD LOSS IN MAN.

Authors:  J T Heyl; J G Gibson; C A Janeway; A Shwachman; L Wojcik
Journal:  J Clin Invest       Date:  1943-11       Impact factor: 14.808
View more
  35 in total

1.  Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis.

Authors:  J H BAXTER; H C GOODMAN; J C ALLEN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

2.  Electrophoretic patterns of the serum proteins in health and disease.

Authors:  F V FLYNN
Journal:  Proc R Soc Med       Date:  1954-10

3.  THE USE OF CONCENTRATED HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER.

Authors:  H G Kunkel; D H Labby; E H Ahrens; R E Shank; C L Hoagland
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

4.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXVI. THE PROPERTIES OF SOLUTIONS OF HUMAN SERUM ALBUMIN OF LOW SALT CONTENT.

Authors:  G Scatchard; L E Strong; W L Hughes; J N Ashworth; A H Sparrow
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

5.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VI. THE OSMOTIC PRESSURE OF PLASMA AND OF SERUM ALBUMIN.

Authors:  G Scatchard; A C Batchelder; A Brown
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

6.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.

Authors:  E J Cohn; J L Oncley; L E Strong; W L Hughes; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

7.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. IX. THE TREATMENT OF SHOCK WITH CONCENTRATED HUMAN SERUM ALBUMIN: A PRELIMINARY REPORT.

Authors:  J V Warren; E A Stead; A J Merrill; E S Brannon
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

8.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXI. THE USE OF SALT-POOR CONCENTRATED HUMAN SERUM ALBUMIN SOLUTION IN THE TREATMENT OF HEPATIC CIRRHOSIS.

Authors:  G W Thorn; S H Armstrong; V D Davenport
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

9.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION XXX. THE USE OF SALT-POOR CONCENTRATED HUMAN SERUM ALBUMIN SOLUTION IN THE TREATMENT OF CHRONIC BRIGHT'S DISEASE.

Authors:  G W Thorn; S H Armstrong; V D Davenport; L M Woodruff; F H Tyler
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

10.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VIII. CLINICAL USE OF CONCENTRATED HUMAN SERUM ALBUMIN IN SHOCK, AND COMPARISON WITH WHOLE BLOOD AND WITH RAPID SALINE INFUSION.

Authors:  A Cournand; R P Noble; E S Breed; H D Lauson; E de F Baldwin; G B Pinchot; D W Richards
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.